Back to search

Article

Exploring the Efficacy of a Novel Cannabidiol and Bevacizumab Combination in Non-Small Cell Lung Cancer

2025-11-10

Abstract excerpt

<title>Abstract</title> <p> Background Lung cancer is the leading cause of cancer-related deaths worldwide. Despite advancements in cancer treatment, the survival rate for patients with non-small cell lung cancer (NSCLC) remains around 15%. Therefore, new therapeutic options are needed for treating the patients with NSCLC. Objectives The study's objective was to investigate the effect of the cannabidiol and beva...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
d8e282c4-1f6d-5b5f-b2da-6cba5ab011f4
DOI
10.21203/rs.3.rs-7737896/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Exploring the Efficacy of a Novel Cannabidiol and Bevacizumab Combination in Non-Small Cell Lung CancerDOI 10.21203/rs.3.rs-7737896/v1
Select a neighboring publication to make it the new centre.